SWITZERLAND – PregLem raises CHF 32m
Sofinnova Partners together with NeoMed Management and MVM LifeScience Partners has co-led a CHF 32m series-A financing round in biopharmaceutical company PregLem.
The funding will allow the company to undertake the development of its compounds for use in reproductive medicine. PregLem was founded in Geneva in 2006 by Dr Ernest Loumaye, a specialist in female reproductive medicine and Eric Rolin, a finance executive.
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Czech Republic-headquartered family office is targeting DACH and CEE region deals
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Ex-Rocket Internet leader Bettina Curtze joins Swiss VC firm as partner and CFO
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Estonia-registered VC could bolster LP base with fresh capital from funds-of-funds or pension funds
Back to Top








